Finanzen von Tenon Medical Inc (TNON)TNONTenon Medical Inc

Evaluating the bottom line, Tenon Medical Inc maintains a gross margin of 63.64%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -262.24%, while the net margin is -316.65%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively TNON converts its operational activities into shareholder value.

In the context of the broader market, TNON competes directly with industry leaders such as OGCP and IVF. With a market capitalization of $1.18M, it holds a significant position in the sector. When comparing efficiency, TNON's gross margin of 63.64% stands against OGCP's N/A and IVF's 28.37%. Such benchmarking helps identify whether Tenon Medical Inc is trading at a premium or discount relative to its financial performance.

Tenon Medical has shown fluctuating revenues, with the most recent quarter (2026/Q2) reporting $1,279,000 in revenue, but it continues to incur significant net losses, with a net income of -$4,050,000. The gross margin has been relatively stable, around 63.64% in the last quarter, but this is overshadowed by the overall financial instability.